RQ Biotechnology
rqbiotechnology.com
Biologics & Biosimilars
Vaccines
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
2
Wellington Management, Oxford Science Enterprises
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Wellington Management 
Oxford Science Enterprises Investors in similar startupsfunds that back the companies most like this one
backs Alloy Therapeutics
Similar startupsby what they do, their industry and backers
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody…
Caedo Oncology AS develops new strategies for monoclonal anti-body based therapy. Learn more about our research and how we work.
Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.
Long-Acting Medicines to Transform Metabolic Health. Pioneering long-acting antibody conjugates to deliver quarterly administered…
Overview
RQ Bio develops long-acting monoclonal antibodies for seasonal influenza, offering immediate, potent, and lasting protection against severe disease.